PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The costs of conflict: Amputees and the Afghan war

A long-term plan to budget for veterans' health care is necessary

2015-06-01
(Press-News.org) Policy makers need to budget more than 288 million pounds over the next 40 years to adequately provide health care to all British soldiers who suffered amputations because of the Afghan war. This is the prediction of Major DS Edwards of the Royal Centre for Defence Medicine in the UK, in a new article appearing in the journal Clinical Orthopaedics and Related Research, published by Springer. He led a study into the scale and long-term economic cost of military amputees following Britain's involvement in Afghanistan between 2003 and 2014.

The authors describe the traumatic amputee as the hallmark of the wounded legacy from Afghanistan. This is in large part because of the extensive use of improvised explosive devices by insurgent groups against the coalition forces. Thanks to better personal protection equipment, improved early medical care, and rapid extraction of the injured, more service members survived such attacks. However, many now have to deal with complex wounds such as multiple amputations. Evidence after the Vietnam War suggests that such military amputees will need medical care and rehabilitation for more than 25 years after their initial injury.

Edwards and his colleagues set out to quantify the extent and nature of traumatic amputations suffered by British service staff from Afghanistan. This was done as a first effort to adequately start budgeting for the long-term needs of the injured beyond their years of service in the armed forces.

They found that between 2003 and 2014, 265 British soldiers sustained 416 amputations. On average the soldiers lost 1.6 limbs each. Of these, 153 soldiers lost their whole leg, while the lower leg of 143 patients was amputated. Including additional treatment cost and economic losses, the total cost or "disease burden" associated with these injuries could be higher than £288 million (USD 444 million) over the next 40 years. This translates to a lifetime cost of around 0.87 million pounds (or 1.34 million dollars) per single below knee military amputee. This is less than was calculated previously for American veterans, but more than the cost associated with civilian trauma amputees.

Over the next decades British military amputees will not only suffer from the same chronic health problems as that of the general population, but also have specific issues related to their injuries. This includes the use of prostheses. The authors believe these impacts can be modified by developing more effective and sustained medical and social support, post-military discharge, in order to encourage healthier lifestyles and develop people's skills and earning capacity. Therefore long-term financial commitment to health care, social services and resources, such as a single point of care, is needed.

"A long-term facility to budget for veterans' health care is necessary," say the authors. "Our estimates should be taken as the start of a challenge to develop sustained rehabilitation and recovery funding and provision."

INFORMATION:

Reference: Edwards, D.S. et al (2015). What Is the Magnitude and Long-term Economic Cost of Care of the British Military Afghanistan Amputee Cohort? Clinical Orthopaedics and Related Research. DOI 10.1007/s11999-015-4250-9

The full-text article is available to journalists on request.



ELSE PRESS RELEASES FROM THIS DATE:

Ancient algae found deep in tropical glacier

Ancient algae found deep in tropical glacier
2015-06-01
HOUSTON - (June 1, 2015) - The remains of tiny creatures found deep inside a mountaintop glacier in Peru are clues to the local landscape more than a millennium ago, according to a new study by Rice University, the University of Nebraska-Lincoln and Ohio State University. The unexpected discovery of diatoms, a type of algae, in ice cores pulled from the Quelccaya Summit Dome Glacier demonstrate that freshwater lakes or wetlands that currently exist at high elevations on or near the mountain were also there in earlier times. The abundant organisms would likely have been ...

A new perspective on Phantom Eye Syndrome

2015-06-01
Researchers from the University of Liverpool have found that approximately half of patients who have an eye removed because of a form of eye cancer experience `phantom eye syndrome.' Patients with the condition experience "seeing" and pain in the eye that is no longer there. Researchers assessed 179 patients whose eye had been removed as a result of a cancer, called intraocular melanoma. They found that more than a third of the patients experienced phantom eye symptoms every day. In most patients, the symptoms ceased spontaneously, but some patients reported that they ...

Highly explosive volcanism at Galapagos

2015-06-01
Understanding the volcanic activity on Earth is not only important in order to limit the impact of natural disasters, volcanic eruptions also have a large impact on the climate and evolution of life on our planet. However, many details in the history of volcanic activity are still unknown. Scientists from the GEOMAR Helmholtz Centre for Ocean Research Kiel, together with colleagues from the USA, Taiwan, Australia and Switzerland, now have been able to track the development of the Galapagos volcanoes in the time frame between eight and 16 million years ago. In the process ...

Insulin degludec: No hint of added benefit in children and adolescents

2015-06-01
Insulin degludec (trade name: Tresiba) has been approved since January 2015 for adolescents and children from the age of one year with type 1 or type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined whether this new drug, alone or in combination with other blood-glucose lowering drugs, offers an added benefit over the appropriate comparator therapy. No added benefit of insulin degludec for adolescents ...

Scientists discover protein that plays key role in streptococcal infections

2015-06-01
The effort to identify new ways of fighting infections has taken a step forward now that scientists have identified a key protein involved in the host's response to strep infections. This protein, called "NFAT," appears to play a key role in the body's inflammatory response to an infection, which when uncontrolled, can be as bad, if not worse, than the infection itself. Furthermore, this discovery was made using streptococcal bacteria, which are responsible for a wide range of human illnesses, ranging from sore throat and pink eye to meningitis and bacterial pneumonia. ...

Thin coating on condensers could make power plants more efficient

2015-06-01
CAMBRIDGE, Mass--Most of the world's electricity-producing power plants -- whether powered by coal, natural gas, or nuclear fission -- make electricity by generating steam that turns a turbine. That steam then is condensed back to water, and the cycle begins again. But the condensers that collect the steam are quite inefficient, and improving them could make a big difference in overall power plant efficiency. Now, a team of researchers at MIT has developed a way of coating these condenser surfaces with a layer of graphene, just one atom thick, and found that this can ...

SIRFLOX study presented at ASCO 2015 Annual Meeting

2015-06-01
Chicago, IL, USA (30 May 2015) -- The benefits of adding liver-directed SIR-Spheres Y-90 resin microspheres to a current systemic chemotherapy for the first-line treatment of unresectable metastatic colorectal cancer (mCRC) reported in the SIRFLOX study, were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The results of the 530-patient SIRFLOX randomized controlled study, which open new possibilities for combining radiation targeted at liver metastases with first-line systemic treatment of mCRC, were presented by Associate Professor ...

PharmaMar's PM1183 plus doxorubicin shows remarkable activity in small cell lung cancer

2015-06-01
Chicago and Madrid, June 1st 2015: PharmaMar today announced data from a Phase 1b study of the transcriptional inhibitor PM1183 in combination with doxorubicin in second line therapy in patients with small cell lung cancer (SCLC) showing that the treatment induced objective responses in 67% of the patients, including 10% of them where all signs of cancer disappeared (complete responses). Every patient with SCLC denominated primary chemotherapy-sensitive (their chemotherapy-free interval (CTFI) is more than 90 days) responded to treatment, including 18% of complete responses. ...

Trabectedin shows activity in ATREUS trial in patients with sarcomatoid malignant mesothelioma

2015-06-01
Chicago and Madrid, June 1st 2015: PharmaMar today announced data from a Phase 2 study in patients with sarcomatoid/biphasic malignant pleural mesothelioma showing that 41.2% (95% CI: 18.4-67.1) of patients treated with the anticancer drug trabectedin in second line were alive and free of progression at 12 weeks. The median progression-free survival (PFS) in these 17 evaluated patients was 8.3 weeks. There were 5 patients who continue receiving trabectedin beyond 12 weeks. "Mesothelioma patients usually do not respond to second-line treatments so the preliminary data ...

Vitamin D and calcium supplements do not improve menopausal symptoms

2015-06-01
PORTLAND, Ore., June 01, 2015 -- Women who took vitamin D and calcium supplements had the same number of menopausal symptoms as women who did not take the supplements, according to a study published today in Maturitas, the official journal of the European Menopause and Andropause Society. The study, which involved 34,157 women ages 50-79, is part of the Women's Health Initiative, one of the largest clinical trials ever undertaken to address the most common causes of death, disability and impaired quality of life in menopausal women. "Our study suggests that women ...

LAST 30 PRESS RELEASES:

Unraveling water mysteries beyond Earth

Signs of multiple sclerosis show up in blood years before symptoms

Ghost particle on the scales

Light show in living cells

Climate change will increase value of residential rooftop solar panels across US, study shows

Could the liver hold the key to better cancer treatments?

Warming of Antarctic deep-sea waters contribute to sea level rise in North Atlantic, study finds

Study opens new avenue for immunotherapy drug development

Baby sharks prefer being closer to shore, show scientists

UBC research helps migrating salmon survive mortality hot-spot

Technical Trials for Easing the (Cosmological) Tension

Mapping plant functional diversity from space: HKU ecologists revolutionize ecosystem monitoring with novel field-satellite integration

Lightweight and flexible yet strong? Versatile fibers with dramatically improved energy storage capacity

3 ways to improve diabetes care through telehealth

A flexible and efficient DC power converter for sustainable-energy microgrids

Key protein regulates immune response to viruses in mammal cells

Development of organic semiconductors featuring ultrafast electrons

Cancer is a disease of aging, but studies of older adults sorely lacking

Dietary treatment more effective than medicines in IBS

Silent flight edges closer to take off, according to new research

Why can zebrafish regenerate damaged heart tissue, while other fish species cannot?

Keck School of Medicine of USC orthopaedic surgery chair elected as 2024 AAAS fellow

Returning rare earth element production to the United States

University of Houston Professor Kaushik Rajashekara elected International Fellow of the Engineering Academy of Japan

Solving antibiotic and pesticide resistance with infectious worms

Three ORNL scientists elected AAAS Fellows

Rice bioengineers win $1.4 million ARPA-H grant for osteoarthritis research

COVID-19 booster immunity lasts much longer than primary series alone, York University-led study shows

Bentham Science joins United2Act

When thoughts flow in one direction

[Press-News.org] The costs of conflict: Amputees and the Afghan war
A long-term plan to budget for veterans' health care is necessary